| Product Code: ETC7658646 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Pediatric Neuroblastoma Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Pediatric Neuroblastoma Treatment Market - Industry Life Cycle |
3.4 Israel Pediatric Neuroblastoma Treatment Market - Porter's Five Forces |
3.5 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Israel Pediatric Neuroblastoma Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pediatric neuroblastoma in Israel |
4.2.2 Technological advancements in pediatric neuroblastoma treatment |
4.2.3 Growing investments in research and development for new treatment options |
4.3 Market Restraints |
4.3.1 High treatment costs associated with pediatric neuroblastoma therapies |
4.3.2 Limited accessibility to advanced treatment options in certain regions of Israel |
5 Israel Pediatric Neuroblastoma Treatment Market Trends |
6 Israel Pediatric Neuroblastoma Treatment Market, By Types |
6.1 Israel Pediatric Neuroblastoma Treatment Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume, By In Vitro Diagnostic (IVD) Devices, 2021- 2031F |
6.1.4 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume, By Cardiology Devices, 2021- 2031F |
6.1.5 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume, By Diagnostic Imaging Devices, 2021- 2031F |
6.1.6 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume, By Anesthesia & Respiratory Care Devices, 2021- 2031F |
6.1.7 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume, By Neonatal ICU Devices, 2021- 2031F |
6.1.8 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume, By Monitoring Devices, 2021- 2031F |
6.1.9 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume, By Home-use Medical Devices, 2021- 2031F |
6.1.10 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume, By Home-use Medical Devices, 2021- 2031F |
6.2 Israel Pediatric Neuroblastoma Treatment Market, By End-user |
6.2.1 Overview and Analysis |
6.2.2 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.2.4 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.2.5 Israel Pediatric Neuroblastoma Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Pediatric Neuroblastoma Treatment Market Import-Export Trade Statistics |
7.1 Israel Pediatric Neuroblastoma Treatment Market Export to Major Countries |
7.2 Israel Pediatric Neuroblastoma Treatment Market Imports from Major Countries |
8 Israel Pediatric Neuroblastoma Treatment Market Key Performance Indicators |
8.1 Average survival rate of pediatric neuroblastoma patients in Israel |
8.2 Number of clinical trials and research studies conducted for pediatric neuroblastoma treatments in Israel |
8.3 Adoption rate of innovative treatment technologies for pediatric neuroblastoma |
9 Israel Pediatric Neuroblastoma Treatment Market - Opportunity Assessment |
9.1 Israel Pediatric Neuroblastoma Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Pediatric Neuroblastoma Treatment Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Israel Pediatric Neuroblastoma Treatment Market - Competitive Landscape |
10.1 Israel Pediatric Neuroblastoma Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel Pediatric Neuroblastoma Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here